ArticleAntimicrobial agents and chemotherapy2011

Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.

Philippe Selhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.